查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363423

美國事後緊急避孕藥市場規模、佔有率和趨勢分析報告：按類型、配銷通路、地區和細分市場預測，2023-2030 年

U.S. Emergency Contraceptive Pills Market Size, Share & Trends Analysis Report By Type (Combination Pills, Progesterone Pills, Ulipristal Acetate), By Distribution Channel (Retail Store, Online Store), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

美國事後緊急避孕藥市場成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，美國事後緊急避孕藥(ECP) 市場預計將達到 51 億美元。

預計2023年至2030年該市場將以5.24%的年複合成長率成長。育齡婦女對 ECP 的接受度不斷提高預計將成為成長的動力。隨著越來越多的女性意識到緊急避孕的重要性和有效性，市場預計將進一步擴大，以滿足對方便可靠的避孕選擇不斷成長的需求。

由於意外懷孕的增加，預計該市場將會成長。這些懷孕會對女性的健康、教育、職業和家庭生活產生負面影響。根據全國家庭成長調查，2017年，有意外懷孕風險的20至44歲女性中，60.3%使用了有效的避孕方法。這些資料凸顯了對可靠的緊急避孕選擇的需求，從而導致市場成長，以滿足尋求避免意外懷孕的女性不斷成長的需求。

主要企業正在實施聯盟、併購、業務擴張和新產品發布等各種策略，以擴大其市場佔有率。這些策略舉措預計將有助於市場成長。例如，2023 年 4 月，生產非處方緊急避孕藥和其他保健品的私人公司Foundation Consumer Healthcare 正在考慮價值 40 億日圓的潛在銷售。該公司於 2017 年從總公司Teva Pharmaceutical Industries收購Plan B One-Step 等事後緊急避孕藥品牌而受到關注。此舉幫助公司獲得了市場的顯著認可。

美國事後緊急避孕藥市場報告亮點

  • 從產品類型來看，由於不同市場參與企業的多種產品的推出以及比其他選擇更高的成功率，黃體酮錠劑在 2022 年佔據最大市場佔有率，超過 45%。
  • 按配銷通路，零售店細分市場在預測期內佔據最大收益佔有率，到 2022 年將超過 55%。在美國，提供來自不同市場參與者的多樣化產品的藥局數量正在增加，預計將推動市場成長。
  • 線上商店部門預計在預測期內成長最快。在美國，網路存取的改善和婦女對事後緊急避孕藥認知的提高預計將推動該領域的成長。
  • 東南亞地區在 2022 年佔據最大的市場佔有率，主要是由於意外懷孕的患病不斷上升。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 市場變數、趨勢和範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 市場趨勢及展望
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 營商環境分析
    • PESTLE分析
    • 波特五力分析
  • COVID-19感染疾病的影響分析

第4章 按類型分類的業務分析

  • 美國事後緊急避孕藥市場：類型變異分析和市場佔有率，2022 年和 2030 年
  • 美國事後緊急避孕藥市場：細分儀表板
  • 避孕藥
  • 黃體酮劑
  • 醋酸烏利司他

第5章 配銷通路業務分析

  • 美國事後緊急避孕藥市場：2022年和2030年配銷通路變化分析和市場佔有率
  • 美國事後緊急避孕藥市場：細分儀表板
  • 零售店
  • 網路商城
  • 其他

第6章 區域業務分析

  • 按地區分類：2022 年和 2030 年美國事後緊急避孕藥市場
  • 東北
  • 東南
  • 中西部
  • 西
  • 西南

第7章 競爭形勢

  • 公司分類
  • 策略規劃
    • 擴張
    • 獲得
    • 合作
    • 新產品發布
    • 其他
  • 公司簡介/名單
    • Afaxys Pharma LLC
    • Teva Pharmaceutical Industries Ltd.
    • Syzygy Healthcare, LLC
    • Gedeon Richter USA, Inc.
    • Rapha Pharmaceuticals, Inc.
    • Perrigo Company plc.
    • Foundation Consumer Healthcare LLC
    • Wockhardt USA
    • Pfizer Inc.
    • Bayer plc
Product Code: GVR-4-68040-110-9

U.S. Emergency Contraceptive Pills Market Growth & Trends:

The U.S. emergency contraceptive pills (ECPs) market size is expected to reach USD 5.1 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to grow at a CAGR of 5.24% from 2023 to 2030. The rising acceptance of ECPs among women of reproductive age is expected to drive the growth. As more women recognize the importance of emergency contraception and its effectiveness, the market is expected to witness further expansion to meet the increasing demand for accessible and reliable contraceptive options.

The market is anticipated to grow owing to the increasing incidence of unintended pregnancies. These pregnancies can adversely affect women's health, education, career, and family life. According to The National Survey of Family Growth, in 2017, 60.3% of women aged 20 to 44 years at risk of unintended pregnancy used effective contraceptive methods. This data highlights the need for reliable emergency contraception options, leading to the market's growth in response to the increasing demand from women who want to avoid unintended pregnancies.

Key players are implementing various strategies such as partnerships, mergers & acquisitions, expansions, and launching new products to expand their market presence. These strategic initiatives are expected to contribute to the market's growth. For instance, in April 2023, Foundation Consumer Healthcare, a private company manufacturing over-the-counter emergency contraceptive pills and healthcare products, is considering a potential sale worth 4 billion. The company gained prominence in 2017 when it acquired emergency contraception brands like Plan B One-Step from Teva Pharmaceutical Industries, based in Israel. This move contributed to the company's significant recognition in the market.

U.S. Emergency Contraceptive Pills Market Report Highlights:

  • Based on type, the progesterone pills segment held the largest market share of over 45% in 2022, owing to the introduction of multiple products from various market players and a high success rate over other options
  • Based on distribution channel, the retail store segment held the largest revenue share of over 55% in 2022 during the forecast period. An increasing number of pharmacies in the U.S. that offers a diverse range of products from different market player is expected to drive the market growth
  • The online store segment is anticipated to witness the fastest growth during the forecast period. The increasing internet accessibility and growing awareness among women about emergency contraceptives in the U.S. are expected to fuel the segment's growth
  • The Southeast region held the largest market share in 2022, primarily due to the increasing prevalence of unplanned pregnancies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources & Third-Party Perspectives
    • 1.4.4. Primary Research
  • 1.5. Information Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Data Visualization
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Increasing awareness about emergency contraception methods
      • 3.3.1.2. Rising prevalence of unintended pregnancies
      • 3.3.1.3. Increased focus on women's health by the government and non-government organizations.
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Product recall
      • 3.3.2.2. Adverse effects associated with the use of contraceptive drugs
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. Porter's Five Forces Analysis
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. U.S. Emergency Contraceptive Pills Market: Type Movement Analysis & Market Share, 2022 & 2030
  • 4.2. U.S. Emergency Contraceptive Pills Market: Segment Dashboard
  • 4.3. Combination Pills
    • 4.3.1. Combination Pills Market, 2018 - 2030 (USD Million)
  • 4.4. Progesterone Pills
    • 4.4.1. Progesterone Pills Market, 2018 - 2030 (USD Million)
  • 4.5. Ulipristal Acetate
    • 4.5.1. Ulipristal Acetate Market, 2018 - 2030 (USD Million)

Chapter 5. Distribution Channel Business Analysis

  • 5.1. U.S. Emergency Contraceptive Pills Market: Distribution Channel Movement Analysis & Market Share, 2022 & 2030
  • 5.2. U.S. Emergency Contraceptive Pills Market: Segment Dashboard
  • 5.3. Retail Store
    • 5.3.1. Retail Store Market, 2018 - 2030 (USD Million)
  • 5.4. Online Store
    • 5.4.1. Online Store Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. U.S. Emergency Contraceptive Pills Market by Region, 2022 & 2030
  • 6.2. Northeast
    • 6.2.1. Northeast Market, 2018 - 2030 (USD Million)
  • 6.3. Southeast
    • 6.3.1. Southeast Market, 2018 - 2030 (USD Million)
  • 6.4. Midwest
    • 6.4.1. Midwest Market, 2018 - 2030 (USD Million)
  • 6.5. West
    • 6.5.1. West Market, 2018 - 2030 (USD Million)
  • 6.6. Southwest
    • 6.6.1. Southwest Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
    • 7.2.1. Expansion
    • 7.2.2. Acquisition
    • 7.2.3. Collaborations
    • 7.2.4. New Product Launches
    • 7.2.5. Others
  • 7.3. Company Profiles/Listing
    • 7.3.1. Afaxys Pharma LLC
      • 7.3.1.1. Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Product Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Teva Pharmaceutical Industries Ltd.
      • 7.3.2.1. Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Product Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Syzygy Healthcare, LLC
      • 7.3.3.1. Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Product Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. Gedeon Richter USA, Inc.
      • 7.3.4.1. Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Product Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Rapha Pharmaceuticals, Inc.
      • 7.3.5.1. Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Product Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. Perrigo Company plc.
      • 7.3.6.1. Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Product Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Foundation Consumer Healthcare LLC
      • 7.3.7.1. Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Product Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. Wockhardt USA
      • 7.3.8.1. Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Product Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. Pfizer Inc.
      • 7.3.9.1. Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Product Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. Bayer plc
      • 7.3.10.1. Overview
      • 7.3.10.2. Financial Performance
      • 7.3.10.3. Product Benchmarking
      • 7.3.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. U.S. Emergency Contraceptive Pills market, by Type, 2018 - 2030 (USD Million)
  • Table 4. U.S. Emergency Contraceptive Pills market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 5. U.S. Emergency Contraceptive Pills market, by Region, 2018 - 2030 (USD Million)

List of Figures

  • Fig 1. Market research process
  • Fig 2. Information procurement
  • Fig 3. Primary research pattern
  • Fig 4. Market research approaches
  • Fig 5. Value chain-based sizing & forecasting
  • Fig 6. Market formulation & validation
  • Fig 7. U.S. emergency contraceptive pills market segmentation
  • Fig 8. Market snapshot, 2022
  • Fig 9. Segment snapshot
  • Fig 10. Competitive landscape snapshot
  • Fig 11. Market trends & outlook
  • Fig 12. Market driver relevance analysis (current & future impact)
  • Fig 13. Market restraint relevance analysis (current & future impact)
  • Fig 14. PESTLE analysis
  • Fig 15. Porter's five forces analysis
  • Fig 16. U.S. emergency contraceptive pills market: Type outlook and key takeaways
  • Fig 17. U.S. emergency contraceptive pills market: Type movement analysis
  • Fig 18. Combination pills market revenue, 2018 - 2030 (USD Million)
  • Fig 19. Progesterone pills market revenue, 2018 - 2030 (USD Million)
  • Fig 20. Ulipristal acetate market revenue, 2018 - 2030 (USD Million)
  • Fig 21. U.S. emergency contraceptive pills market: Distribution channel outlook and key takeaways
  • Fig 22. U.S. emergency contraceptive pills market: Distribution channel movement analysis
  • Fig 23. Retail store market revenue, 2018 - 2030 (USD Million)
  • Fig 24. Online store market revenue, 2018 - 2030 (USD Million)
  • Fig 25. Others market revenue, 2018 - 2030 (USD Million)
  • Fig 26. U.S. emergency contraceptive pills market: Regional outlook and key takeaways
  • Fig 27. U.S. emergency contraceptive pills market: Regional movement analysis
  • Fig 28. Northeast market revenue, 2018 - 2030 (USD Million)
  • Fig 29. Southeast market revenue, 2018 - 2030 (USD Million)
  • Fig 30. Midwest market revenue, 2018 - 2030 (USD Million)
  • Fig 31. West market revenue, 2018 - 2030 (USD Million)
  • Fig 32. Southwest market revenue, 2018 - 2030 (USD Million)
  • Fig 33. Company categorization
  • Fig 34. Strategy mapping
  • Fig 35. Company market position analysis